Kali Inc is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

Employees

Sector

Pharmaceuticals

More about the company

30/07/20	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
16/07/20	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI

Market Cap	1.98M 1.73M 1.6M 1.5M 2.81M 187M 2.87M 19.22M 7.44M 92.23M 7.43M 7.27M 320M	P/E 2011	2.66x	P/E 2012	0.55x
Enterprise Value	-24.94M -21.87M -20.16M -18.87M -35.39M -2.35B -36.13M -242M -93.76M -1.16B -93.67M -91.62M -4.03B	EV / Sales 2011	0.24x	EV / Sales 2012	-0.18x
Free-Float	98.86%	Yield 2011 *	-	Yield 2012	-

30/07/20	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
16/07/20	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI
13/03/20	Puration, Inc. completed the acquisition of Hemp4mula CBD Confections operations of Kali, Inc..	CI
02/03/20	Kali-Extracts, Inc. Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment	CI
12/02/20	Puration, Inc. made a proposal to acquire Hemp4mula CBD Confections operations of Kali, Inc..	CI
04/02/20	Kali, Inc. announced that it expects to receive $20 million in funding	CI
24/01/20	KALY Enters into Discussions with Puration Regarding Pura's Possible Acquisition of KALY's CBD Confection Assets	CI
26/11/19	Kali-Extracts, Inc. Reports Sales Results for the Three Months and Year to Date Ended September 30, 2019; Provides Sales Guidance for the Year 2019	CI
05/11/19	Kali-Extracts, Inc. Announces Plans to Introduce USDA Organic CBD Oil and USDA Organic CBD Infused Beverages	CI
30/10/19	Kali-Extracts Announces Third CBD Extraction Agreement Adding to $15 Million in Current Contracts	CI
30/10/19	Kali Extracts Announces USDA Organic Certification for First Hemp Crop	CI
23/10/19	Kali-Extracts, Inc. Announces New CBD Hemp4mula Gummies Now Available on USMJ.com	CI
11/10/19	Kali-Extracts Is Making CBD Infused Coffee	CI

19/05/21	Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand	AQ
12/05/21	Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	AQ
06/05/21	PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	AQ
13/04/21	Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment	AQ
13/04/21	PAOG Announces Opportunity To Expand CBD Pharmaceutical Research	NE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+7.13%	+9.97%	+55.80%	+160.09%	1,077B
JOHNSON & JOHNSON	+3.99%	+11.50%	+67.09%	+55.96%	613B
ABBVIE INC.	+4.20%	+17.03%	+38.97%	+91.06%	448B
ROCHE HOLDING AG	+0.99%	+4.85%	+28.17%	+23.89%	332B
ASTRAZENECA PLC	+1.82%	+8.19%	+40.04%	+27.95%	293B
NOVARTIS AG	+0.22%	+6.75%	+31.30%	+42.34%	286B
NOVO NORDISK A/S	+0.73%	+8.53%	-27.33%	-39.55%	215B
AMGEN INC.	+1.56%	+6.14%	+29.30%	+60.97%	193B
GILEAD SCIENCES, INC.	+3.26%	+3.33%	+15.55%	+68.24%	159B
Average	+2.66%	+7.72%	+30.99%	+54.55%	401.79B
Weighted average by Cap.	+3.85%	+8.78%	+41.75%	+80.17%

VLOV Inc. Stock Other OTC

Stocks

US9182583024

Pharmaceuticals

Valuation: VLOV Inc.

Latest news : VLOV Inc.

Analysts' recommendations: VLOV Inc.

Press Releases: VLOV Inc.

Other Pharmaceuticals

Financials

Company Profile

	2011	2012
Net sales	88.83M 77.88M 71.79M 67.21M 126M 8.38B 129M 863M 334M 4.14B 334M 326M 14.36B	94.55M 82.9M 76.41M 71.54M 134M 8.92B 137M 918M 355M 4.41B 355M 347M 15.28B
Net income	13.93M 12.21M 11.26M 10.54M 19.76M 1.31B 20.17M 135M 52.35M 649M 52.3M 51.16M 2.25B	17.88M 15.68M 14.45M 13.53M 25.37M 1.69B 25.89M 174M 67.2M 833M 67.13M 65.67M 2.89B
Net Debt	-14.72M -12.91M -11.9M -11.14M -20.89M -1.39B -21.33M -143M -55.35M -687M -55.29M -54.08M -2.38B	-26.92M -23.61M -21.76M -20.37M -38.2M -2.54B -38.99M -262M -101M -1.26B -101M -98.89M -4.35B

End-of-day quote Other OTC Other stock markets
- ^USD	-